These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 30852420)
1. Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3. Puccini A; Loupakis F; Stintzing S; Cao S; Battaglin F; Togunaka R; Naseem M; Berger MD; Soni S; Zhang W; Mancao C; Salhia B; Mumenthaler SM; Weisenberger DJ; Liang G; Cremolini C; Heinemann V; Falcone A; Millstein J; Lenz HJ Eur J Cancer; 2019 Apr; 111():138-147. PubMed ID: 30852420 [TBL] [Abstract][Full Text] [Related]
2. RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICC. Arai H; Cao S; Battaglin F; Wang J; Kawanishi N; Tokunaga R; Loupakis F; Stintzing S; Soni S; Zhang W; Mancao C; Salhia B; Mumenthaler SM; Cremolini C; Heinemann V; Falcone A; Millstein J; Lenz HJ Mol Cancer Ther; 2021 Jun; 20(6):1153-1160. PubMed ID: 33785650 [TBL] [Abstract][Full Text] [Related]
3. Impact of genetic variants involved in the lipid metabolism pathway on progression free survival in patients receiving bevacizumab-based chemotherapy in metastatic colorectal cancer: a retrospective analysis of FIRE-3 and MAVERICC trials. Wang J; Millstein J; Yang Y; Stintzing S; Arai H; Battaglin F; Kawanishi N; Soni S; Zhang W; Mancao C; Cremolini C; Liu T; Heinemann V; Falcone A; Shen L; Lenz HJ EClinicalMedicine; 2023 Mar; 57():101827. PubMed ID: 36816347 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer. Rawłuszko-Wieczorek AA; Siera A; Horbacka K; Horst N; Krokowicz P; Jagodziński PP J Cancer Res Clin Oncol; 2015 Aug; 141(8):1379-92. PubMed ID: 25557833 [TBL] [Abstract][Full Text] [Related]
5. WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy. Bosch LJ; Luo Y; Lao VV; Snaebjornsson P; Trooskens G; Vlassenbroeck I; Mongera S; Tang W; Welcsh P; Herman JG; Koopman M; Nagtegaal ID; Punt CJ; van Criekinge W; Meijer GA; Monnat RJ; Carvalho B; Grady WM Clin Cancer Res; 2016 Sep; 22(18):4612-22. PubMed ID: 27121793 [TBL] [Abstract][Full Text] [Related]
6. The role of LINE-1 methylation in predicting survival among colorectal cancer patients: a meta-analysis. Ye D; Jiang D; Li Y; Jin M; Chen K Int J Clin Oncol; 2017 Aug; 22(4):749-757. PubMed ID: 28343299 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy. Matsusaka S; Hanna DL; Cao S; Zhang W; Yang D; Ning Y; Sunakawa Y; Okazaki S; Berger MD; Miyamato Y; Parekh A; Stintzing S; Loupakis F; Lenz HJ Clin Cancer Res; 2016 Jul; 22(13):3218-26. PubMed ID: 26839145 [TBL] [Abstract][Full Text] [Related]
8. CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer. Kim SH; Park KH; Shin SJ; Lee KY; Kim TI; Kim NK; Rha SY; Ahn JB Yonsei Med J; 2018 Jul; 59(5):588-594. PubMed ID: 29869456 [TBL] [Abstract][Full Text] [Related]
9. Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer. Kang MY; Lee BB; Ji YI; Jung EH; Chun HK; Song SY; Park SE; Park J; Kim DH Cancer; 2008 Apr; 112(8):1699-707. PubMed ID: 18327804 [TBL] [Abstract][Full Text] [Related]
10. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer. de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671 [TBL] [Abstract][Full Text] [Related]
11. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer. Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy. Tokunaga R; Cao S; Naseem M; Lo JH; Battaglin F; Puccini A; Berger MD; Soni S; Millstein J; Zhang W; Stintzing S; Loupakis F; Cremolini C; Heinemann V; Falcone A; Lenz HJ Clin Colorectal Cancer; 2019 Mar; 18(1):e8-e19. PubMed ID: 30293873 [TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive significance of long interspersed nucleotide element-1 methylation in advanced-stage colorectal cancer. Kaneko M; Kotake M; Bando H; Yamada T; Takemura H; Minamoto T BMC Cancer; 2016 Dec; 16(1):945. PubMed ID: 27955637 [TBL] [Abstract][Full Text] [Related]
14. Impact of Colon-Specific DNA Methylation-Regulated Gene Modules on Colorectal Cancer Patient Survival. Yu H; Jiang W; Chen G; Yang F; Zhao X; Ji Z; Ni J; Fu Y; Chen F; Zhao B Med Sci Monit; 2019 May; 25():3549-3557. PubMed ID: 31083646 [TBL] [Abstract][Full Text] [Related]
15. Decoupling of DNA methylation and activity of intergenic LINE-1 promoters in colorectal cancer. Vafadar-Isfahani N; Parr C; McMillan LE; Sanner J; Yeo Z; Saddington S; Peacock O; Cruickshanks HA; Meehan RR; Lund JN; Tufarelli C Epigenetics; 2017 Jun; 12(6):465-475. PubMed ID: 28300471 [TBL] [Abstract][Full Text] [Related]
16. Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer. Okazaki S; Stintzing S; Sunakawa Y; Cao S; Zhang W; Yang D; Ning Y; Matsusaka S; Berger MD; Miyamoto Y; Suenaga M; Schirripa M; West JD; Gopez R; Akihito T; Ichikawa W; Heinemann V; DePaolo RW; Lenz HJ Int J Cancer; 2017 Sep; 141(6):1222-1230. PubMed ID: 28569041 [TBL] [Abstract][Full Text] [Related]
17. The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials. Holch JW; Ricard I; Stintzing S; Modest DP; Heinemann V Eur J Cancer; 2017 Jan; 70():87-98. PubMed ID: 27907852 [TBL] [Abstract][Full Text] [Related]
18. CT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, open-label FIRE-3/AIO KRK0306 trial. Froelich MF; Heinemann V; Sommer WH; Holch JW; Schoeppe F; Hesse N; Baumann AB; Kunz WG; Reiser MF; Ricke J; D'Anastasi M; Stintzing S; Modest DP; Kazmierczak PM; Hofmann FO Eur Radiol; 2018 Dec; 28(12):5284-5292. PubMed ID: 29882070 [TBL] [Abstract][Full Text] [Related]
19. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer. McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398 [TBL] [Abstract][Full Text] [Related]
20. Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials. Sunakawa Y; Stintzing S; Cao S; Heinemann V; Cremolini C; Falcone A; Yang D; Zhang W; Ning Y; Stremitzer S; Matsusaka S; Yamauchi S; Parekh A; Okazaki S; Berger MD; Graver S; Mendez A; Scherer SJ; Loupakis F; Lenz HJ Ann Oncol; 2015 Dec; 26(12):2450-6. PubMed ID: 26416897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]